Who are Riboflavin Sodium Phosphate Injection's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/riboflavin-sodium-phosphate-injection.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Riboflavin Sodium Phosphate Injection — Competitive Intelligence Brief

Riboflavin Sodium Phosphate Injection (Riboflavin Sodium Phosphate Injection) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B2 supplement / Cofactor. Area: Nutritional deficiency / Supportive care.

marketed Vitamin B2 supplement / Cofactor Flavin-dependent enzymes (FAD/FMN-dependent oxidoreductases) Nutritional deficiency / Supportive care Small molecule Live · refreshed every 30 min

Target snapshot

Riboflavin Sodium Phosphate Injection (Riboflavin Sodium Phosphate Injection) — Xijing Hospital of Digestive Diseases. Riboflavin sodium phosphate is a water-soluble form of vitamin B2 that acts as a cofactor for flavin-dependent enzymes involved in cellular energy metabolism and oxidative stress reduction.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Riboflavin Sodium Phosphate Injection TARGET	Riboflavin Sodium Phosphate Injection	Xijing Hospital of Digestive Diseases	marketed	Vitamin B2 supplement / Cofactor	Flavin-dependent enzymes (FAD/FMN-dependent oxidoreductases)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B2 supplement / Cofactor class)

Xijing Hospital of Digestive Diseases · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Riboflavin Sodium Phosphate Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/riboflavin-sodium-phosphate-injection. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab